Skip to main content
Frontiers in Oncology logoLink to Frontiers in Oncology
. 2013 May 30;3:140. doi: 10.3389/fonc.2013.00140

What Makes You Can Also Break You, Part II: Mitochondrial Permeability Transition Pore Formation by Dimers of the F1FO ATP-Synthase?

Gyorgy Szabadkai 1,2, Christos Chinopoulos 3,*
PMCID: PMC3667343  PMID: 23755376

Only a few months ago we commented on the findings by Bonora et al. (2013), regarding the role of the c ring of the F1FO ATP synthase forming the mitochondrial permeability transition (mPT). We forecasted that this is just the opening of yet another shake up in the mitochondrial field, and more studies on the topic will soon follow (Chinopoulos and Szabadkai, 2013). Indeed, now a paper by Giorgio et al. (2013) proposes that the mPT is shaped up by dimers of whole F1FO ATP-synthase complexes.

The deleterious effect of the mPT on cellular metabolism and survival is a fundamental target in cellular pathology, but the lack of knowledge on its molecular identity largely excluded the possibility to exploit its central position in cell death induction. Following a long debate of the presumed components (see Chinopoulos and Szabadkai, 2013 and references therein) cyclophilin D (cypD) emerged as an essential regulator and thus a bona fide component associated with the actual pore. Successively, the group of Bernardi and others (Giorgio et al., 2009; Chinopoulos et al., 2011) have revealed that cypD binds and regulates the F1FO ATP-synthase. Lastly, the present work characterizes the cypD – F1FO ATP-synthase interaction from the point of view of mPT formation, providing evidence that cypD targets the OSCP subunit of the lateral stalk. Moreover, in addition to presenting a series of biochemical and functional evidence indicating that the mPT is correlated with the cypD-OSCP interaction, they directly addressed the pore forming ability of purified F1FO ATP-synthases. It is well established that the mPT represents the opening of a high-conductance channel, called the “mitochondrial megachannel” (MMC), identified by patch-clamping the inner membrane (Kinnally et al., 1989; Petronilli et al., 1989; Szabó et al., 1992; De Marchi et al., 2006). Intriguingly, now Giorgio et al. (2013) show that by incorporating purified F1FO ATP-synthase dimers in liposomes, electrophysiological recordings identical to the MMC can be obtained. Whilst these results provide the most direct evidence so far for mPT pore formation by the F1FO ATP-synthase, again, they raise a series of new questions.

First, in order to obtain a reversible ion permeable pore at the dimerization interface of a membrane protein dimer, two hydrophobic surfaces should be able to provide a hydrophilic lining while the pore is assembled in order to allow ion flow. Then, when the channel is inactivated, these surfaces should become hydrophobic again when the dimer is disassembled, to allow interaction with membrane lipids. In theory, this could be achieved by rotation of amphipathic alpha-helices. If the interpretations of Giorgio et al. are correct, such a helix should be present at the surface of the F1FO ATP-synthase, precisely at the site where two ATP-synthases interact to form the dimers. Unfortunately, there is insufficient knowledge about the structure of the FO portion to validate this possibility. In addition, in spite of the enormous diversity of known gating mechanisms of channels found on the plasma membrane and intracellular organelles, a common denominator is that there is no phospholipid bilayer present in the pore region. Yet, Giorgio et al. showed that the MMC electrophysiological signature can be reproduced by incorporating purified F1FO ATP-synthase dimers in liposomes, where phospholipids are present within and in between the dimers. We can envisage three possibilities to explain their findings: (1) there is channel gating in the presence of an imposing phospholipid bilayer. The concept of a lipidic pore, induced by dimerization of proteins has been proposed previously (Tait and Green, 2010), however, this pore could not exhibit rapid gating properties, which is characteristic of the MMC. (2) An additional protein forms the true pore of the mPT, which is present only in the F1FO ATP-synthase dimeric complexes. This might explain why they have obtained functional pores when reconstituting dimers and not monomers. Relevant to this possibility, the inhibitory factor 1 (IF1) is being increasingly recognized to promote dimerization of the mitochondrial F1FO ATP-synthase (García et al., 2006; Campanella et al., 2008), thus it would be interesting to see if IF1 has any role in mPT formation. (3) The dimerization of the mitochondrial F1FO ATP-synthase distorts either c ring to the point of conferring properties of the MMC. As highlighted in our previous commentary, this idea is not far-fetched (Chinopoulos and Szabadkai, 2013), and would consolidate the findings of Bonora et al. (2013) with the model of Giorgio et al. (2013). Indeed, in their electrophysiological recordings, both F1FO ATP-synthases forming a dimer must have been present within the patched area, thus their results show that dimerization is required for MMC activity, but not that the actual pore forms in between the dimers.

Second, Bernardi's group has previously shown that cells depleted of mitochondrial DNA (rho0 cells) still exhibit mPT (Masgras et al., 2012). The rho0 cells express truncated ATP-synthase monomers since they lack the mitochondrially encoded subunits a and A6L (Carrozzo et al., 2006). In the absence of these subunits, rho0 cells can still form dimeric ATP-synthase structures (mediated by interactions of other subunits) although at considerably reduced amounts due to structural instability of the oligomers (Wittig et al., 2010). However, the very same subunits are critical for the model suggesting mPT formation by ATP-synthase dimers (Bernardi, 2013). Thus the redundancy of subunits a and A6L for mPT in rho0 cells but their necessity for the ATP-synthase dimers formation will require some further clarification.

Third, the results by Giorgio et al. (2013) suggest that the activity of the F1FO ATP synthase has a strong impact on Ca2+ induced mPT. They show that when the complex works in the “reverse” ATP hydrolysis mode, it is far less sensitive to Ca2+ as compared to when it functions in the “forward” ATP synthesis mode. Dimerization of the F1FO ATP-synthase complex has been shown to be associated with increased ATP-synthetic efficiency, again probably driven by associated proteins such as IF1 (Campanella et al., 2008), but this state is usually coupled to increased cell survival, not compatible with mPT. Thus, integrating the pro-death and pro-survival functions in one molecular complex does not seem straightforward.

Nonetheless, now that there is an apparently solid clue regarding the molecular identity of the mPT, a vast amount of functional data that has accumulated in the past few decades of research (reviewed, e.g., in Rasola and Bernardi, 2007; Chinopoulos and Adam-Vizi, 2012) can be re-addressed in light of the scheme proposed by Giorgio et al. (2013). Most of them will appeal to structural biologists: do the histidyl residues mediating the effect of matrix pH on the opening probability of mPT reside on the F1FO ATP-synthase dimers? Where are the redox-sensitive sites (modulated by either matrix pyridine nucleotides or through vicinal thiols depending on GSH pools) which are affected by electron flux and surface potential that probably comprise the voltage-sensor of the mPT? Can they be located on the F1FO ATP-synthase dimers, or do they reside on an interacting protein? Are the critical arginine residues that modulate the voltage dependence and the opening-closing mechanism of the pore, intrinsic to the dimers? Are the F1FO ATP-synthase dimers direct targets of amphipathic anions that favor pore opening, or of polycations, amphipathic cations, and positively charged peptides that inhibit the pore? What is the connection between the established role of electron flow through the respiratory chain complex I in pore opening (Fontaine et al., 1998) and the F1FO ATP-synthase dimers? These and probably a plethora of other questions will likely keep occupied many investigators in the field.

Finally, it will be interesting, but equally challenging to test the validity of this mPT model not just in liposomes but in a living system, probably by using genetic models with modified expression of subunits required for higher order complex formation. Such studies would certainly clarify the pathophysiological relevance of the findings by Giorgio et al. (2013) and set the future directions of this research field, which now has been definitely revived.

Acknowledgments

Gyorgy Szabadkai is supported by the British Heart Foundation, Wellcome Trust, Italian Association for Cancer Research (AIRC), and Telethon Italy. Christos Chinopoulos is supported by the Hungarian Academy of Sciences (MTA-SE Lendület Neurobiochemistry Research Division Grant 95003) and the Hungarian Scientific Research Fund (Grant K 100918).

References

  1. Bernardi P. (2013). The mitochondrial permeability transition pore: a mystery solved? Front. Physiol. 4:95. 10.3389/fphys.2013.00095 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bonora M., Bononi A., De Marchi E., Giorgi C., Lebiedzinska M., Marchi S., et al. (2013). Role of the c subunit of the FO ATP synthase in mitochondrial permeability transition. Cell Cycle 12, 674–683 10.4161/cc.23599 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Campanella M., Casswell E., Chong S., Farah Z., Wieckowski M. R., Abramov A. Y., et al. (2008). Regulation of mitochondrial structure and function by the F1Fo-ATPase inhibitor protein, IF1. Cell Metab. 8, 13–25 10.1016/j.cmet.2008.06.001 [DOI] [PubMed] [Google Scholar]
  4. Carrozzo R., Wittig I., Santorelli F. M., Bertini E., Hofmann S., Brandt U., et al. (2006). Subcomplexes of human ATP synthase mark mitochondrial biosynthesis disorders. Ann. Neurol. 59, 265–275 10.1002/ana.20729 [DOI] [PubMed] [Google Scholar]
  5. Chinopoulos C., Adam-Vizi V. (2012). Modulation of the mitochondrial permeability transition by cyclophilin D: moving closer to F(0)-F(1) ATP synthase? Mitochondrion 12, 41–45 10.1016/j.mito.2011.04.007 [DOI] [PubMed] [Google Scholar]
  6. Chinopoulos C., Konràd C., Kiss G., Metelkin E., Töröcsik B., Zhang S. F., et al. (2011). Modulation of F0F1-ATP synthase activity by cyclophilin D regulates matrix adenine nucleotide levels. FEBS J. 278, 1112–1125 10.1111/j.1742-4658.2011.08026.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chinopoulos C., Szabadkai G. (2013). What makes you can also break you: mitochondrial permeability transition pore formation by the c subunit of the F(1)F(0) ATP-synthase? Front. Oncol. 3:25. 10.3389/fonc.2013.00025 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. De Marchi U., Basso E., Szabò I., Zoratti M. (2006). Electrophysiological characterization of the Cyclophilin D-deleted mitochondrial permeability transition pore. Mol. Membr. Biol. 23, 521–530 10.1080/09687860600907644 [DOI] [PubMed] [Google Scholar]
  9. Fontaine E., Eriksson O., Ichas F., Bernardi P. (1998). Regulation of the permeability transition pore in skeletal muscle mitochondria. Modulation By electron flow through the respiratory chain complex I. J. Biol. Chem. 273, 12662–12668 10.1074/jbc.273.47.31375 [DOI] [PubMed] [Google Scholar]
  10. García J. J., Morales-Ríos E., Cortés-Hernandez P., Rodríguez-Zavala J. S. (2006). The inhibitor protein (IF1) promotes dimerization of the mitochondrial F1F0-ATP synthase. Biochemistry 45, 12695–12703 10.1021/bi060339j [DOI] [PubMed] [Google Scholar]
  11. Giorgio V., Bisetto E., Soriano M. E., Dabbeni-Sala F., Basso E., Petronilli V., et al. (2009). Cyclophilin D modulates mitochondrial F0F1-ATP synthase by interacting with the lateral stalk of the complex. J. Biol. Chem. 284, 33982–33988 10.1074/jbc.M109.020115 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Giorgio V., Von Stockum S., Antoniel M., Fabbro A., Fogolari F., Forte M., et al. (2013). Dimers of mitochondrial ATP synthase form the permeability transition pore. Proc. Natl. Acad. Sci. U.S.A. 110, 5887–5892 10.1073/pnas.1217823110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kinnally K. W., Campo M. L., Tedeschi H. (1989). Mitochondrial channel activity studied by patch-clamping mitoplasts. J. Bioenerg. Biomembr. 21, 497–506 10.1007/BF00762521 [DOI] [PubMed] [Google Scholar]
  14. Masgras I., Rasola A., Bernardi P. (2012). Induction of the permeability transition pore in cells depleted of mitochondrial DNA. Biochim. Biophys. Acta 1817, 1860–1866 10.1016/j.bbabio.2012.02.022 [DOI] [PubMed] [Google Scholar]
  15. Petronilli V., Szabò I., Zoratti M. (1989). The inner mitochondrial membrane contains ion-conducting channels similar to those found in bacteria. FEBS Lett. 259, 137–143 10.1016/0014-5793(89)81513-3 [DOI] [PubMed] [Google Scholar]
  16. Rasola A., Bernardi P. (2007). The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis. Apoptosis 12, 815–833 10.1007/s10495-007-0723-y [DOI] [PubMed] [Google Scholar]
  17. Szabó I., Bernardi P., Zoratti M. (1992). Modulation of the mitochondrial megachannel by divalent cations and protons. J. Biol. Chem. 267, 2940–2946 [PubMed] [Google Scholar]
  18. Tait S. W. G., Green D. R. (2010). Mitochondria and cell death: outer membrane permeabilization and beyond. Nat. Rev. Mol. Cell Biol. 11, 621–632 10.1038/nrm2952 [DOI] [PubMed] [Google Scholar]
  19. Wittig I., Meyer B., Heide H., Steger M., Bleier L., Wumaier Z., et al. (2010). Assembly and oligomerization of human ATP synthase lacking mitochondrial subunits a and A6L. Biochim. Biophys. Acta 1797, 1004–1011 10.1016/j.bbabio.2010.02.021 [DOI] [PubMed] [Google Scholar]

Articles from Frontiers in Oncology are provided here courtesy of Frontiers Media SA

RESOURCES